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Phosphate limitation is an important environmental stress that affects themetabolism of various organisms
and, in particular, can trigger the virulence of numerous bacterial pathogens. Clostridium perfringens, a
human pathogen, is one of the most common causes of enteritis necroticans, gas gangrene and food
poisoning. Here, we focused on the high affinity phosphate-binding protein (PBP-1) of an ABC-type
transporter, responsible for cellular phosphate uptake.We report the crystal structure (1.65 A˚ resolution) of
the protein in complex with phosphate. Interestingly, PBP-1 does not form the short, low-barrier hydrogen
bond with phosphate that is typical of previously characterized phosphate-binding proteins, but rather a
canonical hydrogen bond. In its unique binding configuration, PBP-1 forms an unusually high number of
hydrogen bonds (14) with the phosphate anion. Discrimination experiments reveal that PBP-1 is the least
selective PBP characterised so far and is able to discriminate phosphate from its close competing anion,
arsenate, by ,150-fold.
P
hosphorus is essential for living organisms because it is involved in the composition of critical biomolecules
(e.g., nucleic acids) and in key biological processes1. Although phosphorus is relatively abundant on our
planet, it is mostly trapped in rocks2. Therefore, the bioavailability of phosphorus is limited, and living
organisms have had to develop efficientmechanisms to extract phosphate from the environment3. In prokaryotes,
two main systems have been identified so far: (i) the Phosphate inorganic transport (Pit) and (ii) the Phosphate
specific transport (Pst) systems. The Pit system is a single transmembrane component4,5, that is fueled by the
proton-motive force and transports a divalent metal cation complexed with a phosphate anion6. Pst, the pre-
dominant phosphate transporter7, is a classical ABC-transporter, composed of 5 proteins: 2membrane permeases
(PstA and PstC), 2 ATPases (PstB) and the high-affinity phosphate binding protein PstS (or phosphate-binding
protein, PBP)8. The Pst system is a high-affinity, high-specificity transporter that enables the extraction of
phosphate from the environment9,10, including niches where there are plethora of competing anions, such as
arsenate11. Moreover, the Pst system, as well as other components of the phosphate (Pho) regulon, is directly
involved in bacterial phosphate homeostasis8. Indeed, phosphate starvation may be sensed by the Pst system,
which subsequently signals for the regulation of expression of numerous genes, including genes encoding
virulence factors. Therefore, the Pst system has been linked to bacterial virulence12–15.
The crystal structures of several PstS (or PBP) proteins from various sources have been determined16–19. These
proteins possess a venus-flytrap topology, composed of two globular domains comprising a central b-sheet core
flanked by an a-helix and, linked together with a flexible hinge20. At the interface of both domains lies a
phosphate-binding cleft which comprises 8 residues, forming 12 hydrogen bonds with the phosphate molecule
in several PBPs (e.g., PfluDING19, and inMycobacterium tuberculosis, Escherichia coli, Yersinia pestis17,19,21), and
14 hydrogen bonds in the Borrelia burgdorferi B31 PBP18. Most of the PBPs (e.g., PfluDING, M. tuberculosis, E.
coli and Y. pestis) characterised so far possess a key aspartate residue involved in a short, low barrier hydrogen
bond (LBHB) with the bound phosphate anion17. This bond was shown to be highly selective, and is responsible
for the extremely high selectivity of PBPs over various competing anions such as arsenate (discriminated by,3
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Here, we focus on PBP-1 from Clostridium perfringens, a Gram-
positive bacteria belonging to Clostridia. Mainly anaerobic and able
to form heat-resistant endospores, most Clostridia strains are patho-
genic for both humans and animals, and produce potent extracellular
toxins such as tetanus or botulinum neurotoxins22. Among them, C.
perfringens is responsible for more than 42% of clostridial human
infection23 and causes numerous cases of enteritis necroticans, gas
gangrene (also called clostridial myonecrosis) and food poison-
ing22,24–26. In such pathogenic bacteria, the phosphate ABC trans-
porter components, involved in bacterial pathogenicity and
virulence, constitute interesting putative targets for vaccine
development27.
We report the crystal structure of a PBP-1 from the C. perfringens
strain ATCC 13124 in the F222 space group, and compare it to other
known PBP structures. We highlight that, as for B. burgorferi B31
PBP, C. perfringens PBP-1 forms 14 hydrogen bonds, but no LBHB,
with the bound phosphate anion. Using an in vitro discrimination
assay, we show that PBP-1 is less discriminating towards arsenate
(,200-fold) than previously reported PBPs (,700 to 5000-fold11),
possibly relevant to function.
Methods
Production and purification of the C. perfringens PBP-1. The gene encoding the
phosphate-binding protein of Clostridium perfringens ATCC 13124 (C. perfringens)
was optimized for heterologous expression in Escherichia coli (E. coli) and synthetised
by Genwiz (South Plainfield, New Jersey, USA). The gene was cloned into a pET22b
(1) plasmid, using NcoI and NotI as cloning sites. Protein production and
purification was performed in the E. coli strain BL21(DE3)-pGro7/GroEL (TaKaRa)
in ZYP medium28 (complemented with 100 mg.ml21 ampicillin and 34 mg.ml21
chloramphenicol). The cultures were grown at 37uC to reachOD600nm5 0.6 and were
then induced by the lactose consumption of ZYPmedium coupled with a temperature
transition to 17uC over 16 h. Cells were harvested by centrifugation (4 500 g, 4uC,
15 min) and pellets were suspended in lysis buffer (20 mM TRIS, pH 8, 100 mM
NaCl, Lysozyme 0.25 mg.ml21, DNAse I 10 mg.ml21, PMSF 0.1 mM,MgSO4 20 mM
and EDTA-free anti-protease (Roche)) and stored at 280uC for 2 h. Partially lysed
cells were thawed at 37uC for 15 min and disrupted by 3 30 sec sonication steps
(QSonica sonicator; amplitude 30). Debris was removed by centrifugation (12 500 g,
4uC, 30 min). The supernatant was then loaded onto a Nickel affinity column
(HisTrap 5 ml, FFCrude from GE Healthcare) at a flow rate of 5 ml.min21. Proteins
attached to the column were eluted by imidazole competition using an elution buffer
(20 mM TRIS, pH 8, 100 mM NaCl and 250 mM imidazole). Then, a size exclusion
chromatography step (Superdex 75 16/60, GE Healthcare) was performed using a
20 mM TRIS, pH 8 and 100 mM NaCl buffer. Protein production and purity were
checked by 15% SDS-PAGE analysis. Protein concentrations were quantified using
Nanodrop 2000c (Thermo-scientific, Illkirch, France) by measuring the absorbance
e0.1% 5 0.547 g/l at 280 nm (based on the calculation from ProtParam29).
Crystallisation of the C. perfringens PBP-1. C. perfringens PBP-1 was concentrated
up to 60 mg.ml21 using a centrifugation device (Vivaspin 500, MWCO 3 kDa,
Sartorius, Germany). The best conditions for crystallisation were screened for using a
commercial kit (Wizard I and II, Molecular Dimension, England) at 298 K with a
Mosquito instrument (TTP Labtech, England). The sitting-drop vapour diffusion
method setup in a 96-well plate was used with 2 protein5reservoir ratios (151 and
251). Drops were monitored with a Discovery V8 binocular microscope (Zeiss,
Germany). Crystals of 150–200 mmwere obtained in the condition containing 0.1 M
Sodium Acetate, 0.2 M Zinc Acetate pH 4.5 and 10% PEG 3000 at both ratios. To
obtain bigger crystals, an optimisation of this condition was performed using the
hanging drop method and a ratio of 151 (protein5reservoir, 500 nL5500 nL). This
led to the creation of reproducible crystals of 200–250 mm after 3 days at 298 K.
Data collection, molecular replacement and refinement. Crystals were transferred
for a few seconds in a drop (1 mL) containing a cryo-protectant solution made out of
the crystallisation solution and 10% (v/v) of glycerol. After being mounted on a
CryoLoop (Hampton research), crystals were flash-frozen in liquid nitrogen. X-ray
diffraction intensities were collected on the ID29-2 beamline at the ESRF (Grenoble,
France) with 0.1 s exposure times. Diffraction data were collected from 2000 images;
each frame consisted of 0.1u step oscillations, over a range of 200u (Table 1). The
molecular replacement was performed using Phaser30 and PDB 4GD5 as a starting
model. Refinement was carried out with REFMAC5 and Phenix31,32. The model was
improved using Coot33. Themodel and structure factors were deposited in the Protein
Data Bank code, ID 4Q8R.
Discrimination assay. The discrimination assay was performed as previously
described11. Briefly, the ability of PBP-1 to discriminate phosphate from arsenate was
tested by dialysing PBP-1 against a competition buffer, made of 50 mM Tris-HCl
buffer pH 8.0, containing 140 nM phosphate (with 1 mCi of radiolabelled phosphate
32P; Perkin Elmer NEX053011MC), and varying concentrations of arsenate (from
0.1 mM to 100 mM). The protein was diluted to 5 mM into a buffer made of 50 mM
Tris-HCl buffer pH 8.0 and 0.1% BSA (Sigma), and placed in dialysis units (Thermo
Scientific). These units were placed in 50 mL tubes containing the competition buffer
and incubated 24 hours, at room temperature, with gentle shaking. The intake of
radiolabelled phosphate by PBP-1 was measured by the radioactivity of 250 mL of the
protein sample and of the outer buffer. These samples were added to 4 mL of
scintillation liquid (Ultima Gold, Perkin Elmer) andmeasured in a liquid scintillation
analyser (Packard TRE-CARB 2100TR). The experiment was performed in four
independent replicates, and included a control without PBP-1. The background
adsorption by 0.1% BSA was#1000-fold relative to the PBP-1 signal. The measured
level of radioactivity of the protein solution (PBP bound to radiolabelled phosphate)
in conditions containing no arsenate corresponded to 100% binding (or 0%
replacement). Conversely, the background level of radioactivity in the dialysis tube
corresponded to 0% binding (or 100% replacement). The replacement values were
plotted using GraphPad Prism software (v.5) and fitted to the sigmoidal equation (1):
Replacement~
100
1z10 Log R50{xð Þ|mð Þ
ð1Þ
R50 is the ratio [arsenate]/[phosphate] yielding 50% replacement, and m is the
sigmoidal slope factor.
Points that do not coincide with the fitted slope (e.g., for 100% or 0% replacement)
are due to experimental errors of the system.
Results
C. perfringens PBP-1 crystal structure. C. perfringens PBP-1 is a
relatively distant protein from the known P. fluorescens PBP
(PfluDING) and E. coli PstS (41 and 52% sequence similarity; 13
and 25% sequence identity, respectively). C. perfringens PBP-1 is
closer to B. burdgorferi B31 PBP (70% sequence similarity; 28%
sequence identity) (Fig. 1). C. perfringens PBP-1 was overexpressed
in E. coli strain BL21(DE3)-pGro7/EL and purified (Fig. S1) with a
significant yield, ,30 mg of protein per litre of culture. The crystal
structure ofC. perfringensPBP-1was determined at 1.65 A˚ resolution
in the F222 space group (Fig. 2A; Table 1). The PBP-1 structure
exhibits two globular domains, each one composed of a central
core b-sheets flanked by a-helices. Both domains are linked
together with a flexible hinge. This topology, known as a Venus
flytrap, is believed to adopt an open state while empty and to close
upon ligand binding20,34.







Number of frames 2000
Resolution (A˚) (last bin) 1.65 (1.752 1.65)
Space group F222
Unit-cell parameters (A˚) a 5 70.78; b 5 105.73; c 5
146.45
No. of observed reflections (last bin) 240770 (38721)
No. of unique reflections (last bin) 33133 (5276)
Completeness (%)(last bin) 99.9 (100)
Rmeas (%) (last bin) 4.3 (62.8)
CC (1/2) (last bin) 100 (89.7)
I/s(I) (last bin) 25.76 (3.37)
Redundancy (last bin) 7.26 (7.33)
Refinement statistics
Rfree/Rwork 17.73/13.44
No. of total model atoms 2091
Ramachandran favoured (%) 99.6
Ramachandran outliers (%) 0
Generously allowed rotamers (%) 0.4
Rmsd from ideal
Bond lengths (A˚) 0.019
Bond angles (u) 1.82
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The structure of C. perfringens PBP-1 was also solved in another
space group (P21) at a similar resolution (1.7 A˚) by the Center for
Structural Genomics of Infectious Diseases (PDB ID: 4GD5). As
expected, both structures are nearly superimposed (RSMD on
a-carbon 5 0.275 A˚); interestingly, however, some regions adopt
significantly different conformations, e.g., two surface helices are
shifted by .1 A˚ between both structures (Fig. S2). The structural
cause for these different conformations is not obvious from the
Figure 1 | Sequence alignment of PBPs. Sequences from Hypericum perforatum PBP (p27SJ, gb |AY866430.1), Pseudomonas fluorescens SBW 25 PBP
(PfluDING, YP_002872028.1), Escherichia coli PBP (PBP_E. coli, WP_000867147.1), B. burgdorferi B31 PBP (PBP_B.burd, NP_212349.2), and both C.
perfringens PBPs (PBP1_C.per, YP_695070.1 and PBP2_C.per, YP_695071.1) were aligned using T-COFFEE Expresso41 and were manually refined.
Residues involved in phosphate binding are highlighted in green.
www.nature.com/scientificreports
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structures, and may be due to the different crystallisation conditions
and/or to the different crystal packings.
Structural comparison with other PBPs. C. perfringens PBP-1 is
shorter (246 residues) than most of PBPs characterised thus far: the
PBPs from E. coli and PfluDING are indeed much larger (321 and
371 residues, respectively). This discrepancy is strikingly visible
while superposing their respective structures. In particular, while
the ‘‘frontside’’ of the protein (right, in Fig. 2B), i.e. the part that
binds phosphate and putatively interacts with the transporter is
similar, the ‘‘backside’’ (left, in Fig. 2B) of the C. perfringens PBP-1
seems to be missing. In fact, a significant loop fragment and C-
terminus fragment are ‘‘missing’’ compared with the E. coli or P.
fluorescens PBPs. Remarkably, C. perfringens PBP-1 is very similar
in size to p27SJ, a biologically active albeit truncated form of a PBP
called p38SJ (38 kDa) isolated from St John’s Wort35. Interestingly,
this truncated form modulates the cell cycle of human cells and
inhibits HIV-1 replication35,36. The structure of C. perfringens PBP-
1 is closer to that of B. burgdorferi B31 PBP, although it is important
to note that both structures are not in the same state: the B.
burgdorferi B31 PBP was crystallized in the absence of ligand, and
is therefore in the ‘‘open’’ state, whereas C. perfringens PBP-1 is
bound to phosphate and adopts a ‘‘closed’’ conformation (Fig. 2C).
B. burgdorferi B31 PBP and C. perfringens PBP-1 shares only 28%
sequence identity, but the structural comparison of both structures
suggests that these PBPs undergoes dramatic conformational
changes upon phosphate binding/release (Fig. S3A&B). Indeed, the
binding site residue Arg125 in PBP-1 (bound state) is about 10 A˚
away from its corresponding residue in the B. burgdorferi B31 PBP
structure (free state). Interestingly, the conformational changes in
the binding/release motion may not only relate to a rigid body
motion of the two globular domains along the flexible hinge
(‘‘venus flytrap’’ motion) but might also involve some secondary
structure reorganisations, as seen for Helix 7 (Fig. S3B).
The phosphate-binding site. The structure of C. perfringens PBP-1
bound to phosphate reveals that the protein forms 14 hydrogen
bonds with the anion, via 9 different residues (Fig. 3A). The
phosphate anion is completely sequestered, buried between the two
protein domains, with no solvent accessibility. The phosphate anion
interacts with 5 backbone N-H group (Thr12, Ser13, Ser41, Gly130,
Thr131), 6 side chain O-H groups (Ser11, Thr12, Ser41, Ser59,
Thr131, Ser129) and 2 side chain N-H2 groups (Arg125) (Fig. 3B).
Although the structure resolution (1.65 A˚) does not allow for the
direct location of hydrogen atoms from the electron density maps, a
careful analysis of the position of the residues interacting with the
phosphate anion, as well as of the neighbouring residues, enables us
to establish a hypothetical hydrogen bond network. Assuming that,
similarly to what was previously observed, including at acidic pH
(4.5)19, C. perfringens PBP-1 binds dibasic phosphate, the only
proton carried by the phosphate moiety may be accepted by Ser13
side chain O-H: indeed it appears to be the only group with a riding
hydrogen atom that does not already unambiguously accept a
hydrogen atom from another protein residue (Fig. S4). Moreover,
the case of phosphate O4 is intriguing: in addition to the hydrogen
bond it forms with Ser13, it is located at distances (between 2.6 to 3.1
A˚) and angles (between 108 to 131u) that are compatible with 3 more
hydrogen bonds, with Ser13 (main chain NH group), Ser59 (side
chain –OH), and Ser11 (side chain –OH). Phosphate O2 only has
two free electron doublets and, is likely to form two hydrogen bonds
out of these three possible interactions.We surmise that this is due to
the tremendous tightness and contact density within the phosphate-
binding site, as previous described in PBPs11.
Compared with other PBPs (from E. coli, Y. pestis, M. tuberculosis
PBPs or PfluDING), the C. perfringens PBP-1 forms 2 additional
hydrogen bonds with the phosphate anion (14 versus 12 in other
PBPs). These two additional bonds are made possible by 2 amino
acids substitutions in the phosphate binding pocket: a substitution of
an alanine into serine (Ala11Ser according to the numbering of C.
perfringens PBP-1) and a substitution of a leucine into serine
(Leu13Ser) (Fig. 3C). Notably, these two substitutions occur in resi-
dues putatively involved in repulsive interactions with the bound
anion11, replacing them by hydrogen bonds. A third substitution also
replaces the short (2.50 A˚)17, Low barrier Hydrogen Bond (LBHB)
formed between the phosphate anion and an aspartate residue, with a
serine residue (Asp59Ser). The distance between the Ser11 O-H and
the phosphate’ O2 of 2.7 A˚, suggests a classical hydrogen bond.
PBP-1 is less discriminant than other PBPs. A previous work on
PBPs highlighted the link between the bonds involved in phosphate
binding, and the ability of PBPs to discriminate phosphate and close
Figure 2 | Structural analysis of C. perfringens PBP-1 and structural comparison with other PBPs. (A). Structure of the C. perfringens PBP-1. Domains
are colourised in cyan and green, whereas b-sheets from the hinge are colourised in yellow. (B). Structures of C. perfringens and E. coli PBPs are
represented by lines and colourised in blue and green, respectively. The phosphate molecule is represented as a sphere. (C). Structures of PBP-1 from C.
perfringens and B. burgdorferi are represented as lines and colourised in blue and orange, respectively. The phosphate molecule is represented as a sphere.
www.nature.com/scientificreports
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competing anions such as arsenate11. The case of C. perfringens PBP-1
is indeed interesting, as it forms 14 hydrogen bonds with the
phosphate anion, whereas the highly discriminating PBPs form 12.
Discrimination experiments reveal that C. perfringens PBP-1
discriminates between phosphate and the very close arsenate, albeit
only by,150-fold (Fig. 3D). This result is interesting, as it reveals that
C. perfringens PBP-1 is the least discriminating PBP tested thus far.
Discussion
C. perfringens PBP-1 exhibits a reduced selectivity. The crystal
structure of C. perfringens PBP-1 reveals an interesting phosphate
binding cleft, that significantly differs from that of other known
PBPs. C. perfringens PBP-1 binds phosphate via 9 residues and 14
hydrogen bonds, whereas most of previously characterised PBPs
utilise 8 residues, 11 hydrogen bonds and 1 short, Low Barrier
H-bond (LBHB). A recent work highlighted the role of the LBHB
in the tremendous anion selectivity of PBPs11 and suggested that the
LBHB is the main determinant for the discrimination of PBPs.
Interestingly, C. perfringens PBP-1 does not form a LBHB with
phosphate, but rather 2 additional classical hydrogen bonds (14
total). Here, we show that PBP-1 is the least discriminating PBP
isolated thus far, capable of discriminating phosphate from the clos-
est competing anion, arsenate by ,150-fold, whereas other tested
PBPs all discriminate by .500-fold11.
Notably, the selectivity of C. perfringens PBP-1 is only slightly
higher than that of PBP mutants where the LBHB was suppressed
(discrimination factors of 50 to 75-fold11). Therefore, we surmise that
the observed reduced discrimination capacity of PBP-1 is the result
of its unique phosphate-binding configuration. This hypothesis
requires further investigations.
Relationship between selectivity and environment. The use of a
different phosphate binding strategy than the other characterized
PBPs is intriguing, especially because the differences include a key,
unique bond formed between the phosphate anion and the PBP. The
reduced ability of C. perfringens PBP-1 to discriminate phosphate
Figure 3 | The phosphate-binding site of the C. perfringens PstS. (A). Phosphate-binding cleft: The phosphate anion is sequestered via 14 hydrogen
bonds (black dashes) formed with the protein (shown as blue sticks). (B). Hydrogen bonding network. The 14 hydrogen bonds between the phosphate
anion and the protein (in dashes) and the interaction distances (in A˚), are highlighted. Blue dashes indicate hydrogen bonds that are unique to C.
perfringens PBP-1. (C). Superposition of the phosphate-binding sites from PBP-1 (blue sticks) and PfluDING (grey sticks; PDB ID 4F1V). Only the
interactions with the phosphate anion (in ball and sticks) in PBP-1, which differ from those in PfluDING, are shown (black dashes). (D). The phosphate-
arsenate selectivity of PBP-1. Increasing arsenate concentrations were used to compete with a constant, radiolabelled phosphate concentration for
binding to PBP-1. The level of measured radioactivity (or protein-bound radiolabelled phosphate) corresponds to 0% replacement when no arsenate is
bound to the protein. When all the protein is bound to arsenate, replacement is 100%.
www.nature.com/scientificreports
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from arsenate might be linked to the life cycle of this organism.
Indeed, C. perfringens, which lives in sediments and soils37, as well
as in the intestinal tracks of humans and other vertebrates26, might
not have as critical a need as other soils or water-living organisms to
prevent arsenate uptake.
However, the absence of a LBHB, and/or the relatively low select-
ivity of C. perfringens PBP-1 might also relate to a functional adapta-
tion, providing or improving upon a property of the PBP that is
beneficial forC. perfringens. Given the recently reported involvement
of PBPs (or pstS) in bacterial virulence8,38,39, future studies should
assess, among other features, the phosphate transport rates and the
phosphate binding affinity of PBP-1. In particular, given the facts
that the LBHB of PBPs have been previously reported not to be
critical for phosphate binding11,40, and that substitutions Ala11Ser
and Leu13Ser putatively replace the repulsive interactions by hydro-
gen bonds, the affinity of PBP-1 for phosphate might differ from that
of other PBPs.
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